{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-022145","form_type":"8-K","ticker":"LFMD","cik":"0000948320","company_name":"LifeMD, Inc.","filed_at":"2023-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.967475+00:00","generated_at":"2026-06-13T19:37:47.613037+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"LifeMD appoints William Febbo (OptimizeRx CEO) to Board; Galluppi resigns as director","bullets":["Stefan Galluppi resigns from Board effective June 20, 2023; no disagreement; continues as Chief Innovation Officer.","William Febbo appointed to Board; receives 75,000 restricted shares (half vest immediately) and 37,500 stock option.","Febbo also entered consulting agreement May 30 for 375,000 restricted shares vesting quarterly through Nov 2024.","Febbo is CEO of OptimizeRx (OPRX) with 25+ years in healthcare and digital health."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-022145","json":"https://secwatch.observer/filing/0001493152-23-022145.json","markdown":"https://secwatch.observer/filing/0001493152-23-022145.md","text":"https://secwatch.observer/filing/0001493152-23-022145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/948320/000149315223022145/0001493152-23-022145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/948320/000149315223022145/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T19:37:47.613037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52cfaa414f","claim":"Stefan Galluppi resigned as Director at LifeMD, Inc..","evidence_excerpt":"On June 20, 2023, Stefan Galluppi resigned from the Board of Directors of LifeMD, Inc. (the \"Company\") effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/948320/000149315223022145/0001493152-23-022145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"63e3c40783","claim":"William J. Febbo was appointed as Director at LifeMD, Inc..","evidence_excerpt":"On June 20, 2023, William J. Febbo was appointed to the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/948320/000149315223022145/0001493152-23-022145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}